Modification of pIX or hexon based on fiberless Ad vectors is not effective for targeted Ad vectors

Journal of Controlled Release

Volumn 127, Issue 1, 2008, Pages 88-95

  Kurachi, Shinnosuke ^a,b   Koizumi, Naoya ^a   Tashiro, Katsuhisa ^a,b   Sakurai, Haruna ^a,b   Sakurai, Fuminori ^a   Kawabata, Kenji ^a   Nakagawa, Shinsaku ^b   Mizuguchi, Hiroyuki ^a,b  

^a NATIONAL INSTITUTE OF BIOMEDICAL INNOVATION   (Japan)

^b OSAKA UNIVERSITY   (Japan)

Author keywords

Adenovirus vector; Fiber; Gene therapy; Hexon; pIX; Targeting

Indexed keywords

FIBERS; GENE EXPRESSION; LIGANDS; PROTEINS;

ADENOVIRUS VECTOR; GENE THERAPY;

VECTORS;

ADENOVIRUS VECTOR; POLYHISTIDINE TAG; PROTEIN; PROTEIN IX; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; FIBER; GENE EXPRESSION; GENE TRANSFER; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; PRIORITY JOURNAL; THERMOSTABILITY;

EID: 40649118932     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jconrel.2007.12.016     Document Type: Article

References (48)

1. H. Mizuguchi T. Hayakawa Targeted adenovirus vectors Hum. Gene Ther. 15 2004 1034 1044
2. A.L. Parker S.N. Waddington C.G. Nicol D.M. Shayakhmetov S.M. Buckley L. Denby G. Kemball-Cook S. Ni A. Lieber J.H. McVey S.A. Nicklin A.H. Baker Multiple vitamin K-dependent coagulation zymogens promote adenovirus-mediated gene delivery to hepatocytes Blood 108 2006 2554 2561
3. D.M. Shayakhmetov A. Gaggar S. Ni Z.Y. Li A. Lieber Adenovirus binding to blood factors results in liver cell infection and hepatotoxicity J. Virol. 79 2005 7478 7491
4. R. Alemany D.T. Curiel CAR-binding ablation does not change biodistribution and toxicity of adenoviral vectors Gene Ther. 8 2001 1347 1353
5. D.A. Einfeld R. Schroeder P.W. Roelvink A. Lizonova C.R. King I. Kovesdi T.J. Wickham Reducing the native tropism of adenovirus vectors requires removal of both CAR and integrin interactions J. Virol. 75 2001 11284 11291
6. H. Mizuguchi N. Koizumi T. Hosono A. Ishii-Watabe E. Uchida N. Utoguchi Y. Watanabe T. Hayakawa CAR- or alphav integrin-binding ablated adenovirus vectors, but not fiber-modified vectors containing RGD peptide, do not change the systemic gene transfer properties in mice Gene Ther. 9 2002 769 776
7. I. Kirby E. Davison A.J. Beavil C.P. Soh T.J. Wickham P.W. Roelvink I. Kovesdi B.J. Sutton G. Santis Mutations in the DG loop of adenovirus type 5 fiber knob protein abolish high-affinity binding to its cellular receptor CAR J. Virol. 73 1999 9508 9514
8. M.C. Bewley K. Springer Y.B. Zhang P. Freimuth J.M. Flanagan Structural analysis of the mechanism of adenovirus binding to its human cellular receptor, CAR Science 286 1999 1579 1583
9. P. Leissner V. Legrand Y. Schlesinger D.A. Hadji M. van Raaij S. Cusack A. Pavirani M. Mehtali Influence of adenoviral fiber mutations on viral encapsidation, infectivity and in vivo tropism Gene Ther. 8 2001 49 57
10. P.W. Roelvink G. Mi Lee D.A. Einfeld I. Kovesdi T.J. Wickham Identification of a conserved receptor-binding site on the fiber proteins of CAR-recognizing adenoviridae Science 286 1999 1568 1571
11. T. Smith N. Idamakanti H. Kylefjord M. Rollence L. King M. Kaloss M. Kaleko S.C. Stevenson In vivo hepatic adenoviral gene delivery occurs independently of the coxsackievirus-adenovirus receptor Mol. Ther. 5 2002 770 779
12. T. Nakamura K. Sato H. Hamada Reduction of natural adenovirus tropism to the liver by both ablation of fiber-coxsackievirus and adenovirus receptor interaction and use of replaceable short fiber J. Virol. 77 2003 2512 2521
13. S.S. Hong M.K. Magnusson P. Henning L. Lindholm P.A. Boulanger Adenovirus stripping: a versatile method to generate adenovirus vectors with new cell target specificity Mol. Ther. 7 2003 692 699
14. V. Krasnykh N. Belousova N. Korokhov G. Mikheeva D.T. Curiel Genetic targeting of an adenovirus vector via replacement of the fiber protein with the phage T4 fibritin J. Virol. 75 2001 4176 4183
15. M.K. Magnusson S.S. Hong P. Henning P. Boulanger L. Lindholm Genetic retargeting of adenovirus vectors: functionality of targeting ligands and their influence on virus viability J. Gene Med. 4 2002 356 370
16. D.J. Von Seggern C.Y. Chiu S.K. Fleck P.L. Stewart G.R. Nemerow A helper-independent adenovirus vector with E1, E3, and fiber deleted: structure and infectivity of fiberless particles J. Virol. 73 1999 1601 1608
17. V. Legrand D. Spehner Y. Schlesinger N. Settelen A. Pavirani M. Mehtali Fiberless recombinant adenoviruses: virus maturation and infectivity in the absence of fiber J. Virol. 73 1999 907 919
18. E. Vigne J.F. Dedieu A. Brie A. Gillardeaux D. Briot K. Benihoud M. Latta-Mahieu P. Saulnier M. Perricaudet P. Yeh Genetic manipulations of adenovirus type 5 fiber resulting in liver tropism attenuation Gene Ther. 10 2003 153 162
19. T.A. Smith N. Idamakanti M.L. Rollence J. Marshall-Neff J. Kim K. Mulgrew G.R. Nemerow M. Kaleko S.C. Stevenson Adenovirus serotype 5 fiber shaft influences in vivo gene transfer in mice Hum. Gene Ther. 14 2003 777 787
20. T.A. Smith N. Idamakanti J. Marshall-Neff M.L. Rollence P. Wright M. Kaloss L. King C. Mech L. Dinges W.O. Iverson A.D. Sherer J.E. Markovits R.M. Lyons M. Kaleko S.C. Stevenson Receptor interactions involved in adenoviral-mediated gene delivery after systemic administration in non-human primates Hum. Gene Ther. 14 2003 1595 1604
21. N. Koizumi K. Kawabata F. Sakurai Y. Watanabe T. Hayakawa H. Mizuguchi Modified adenoviral vectors ablated for coxsackievirus-adenovirus receptor, alphav integrin, and heparan sulfate binding reduce in vivo tissue transduction and toxicity Hum. Gene Ther. 17 2006 264 279
22. N. Koizumi H. Mizuguchi F. Sakurai T. Yamaguchi Y. Watanabe T. Hayakawa Reduction of natural adenovirus tropism to mouse liver by fiber-shaft exchange in combination with both CAR- and alphav integrin-binding ablation J. Virol. 77 2003 13062 13072
23. H. Mizuguchi N. Koizumi T. Hosono N. Utoguchi Y. Watanabe M.A. Kay T. Hayakawa A simplified system for constructing recombinant adenoviral vectors containing heterologous peptides in the HI loop of their fiber knob Gene Ther. 8 2001 730 735
24. N. Koizumi H. Mizuguchi N. Utoguchi Y. Watanabe T. Hayakawa Generation of fiber-modified adenovirus vectors containing heterologous peptides in both the HI loop and C terminus of the fiber knob J. Gene Med. 5 2003 267 276
25. S. Kurachi N. Koizumi F. Sakurai K. Kawabata H. Sakurai S. Nakagawa T. Hayakawa H. Mizuguchi Characterization of capsid-modified adenovirus vectors containing heterologous peptides in the fiber knob, protein IX, or hexon Gene Ther. 14 2007 266 274
26. W. Arap R. Pasqualini E. Ruoslahti Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model Science 279 1998 377 380
27. J.T. Douglas C.R. Miller M. Kim I. Dmitriev G. Mikheeva V. Krasnykh D.T. Curiel A system for the propagation of adenoviral vectors with genetically modified receptor specificities Nat. Biotechnol. 17 1999 470 475
28. P. Lindner K. Bauer A. Krebber L. Nieba E. Kremmer C. Krebber A. Honegger B. Klinger R. Mocikat A. Pluckthun Specific detection of his-tagged proteins with recombinant anti-His tag scFv-phosphatase or scFv-phage fusions Biotechniques 22 1997 140 149
29. H. Mizuguchi M.A. Kay A simple method for constructing E1- and E1/E4-deleted recombinant adenoviral vectors Hum. Gene Ther. 10 1999 2013 2017
30. H. Mizuguchi M.A. Kay Efficient construction of a recombinant adenovirus vector by an improved in vitro ligation method Hum. Gene Ther. 9 1998 2577 2583
31. J.V. Maizel Jr. D.O. White M.D. Scharff The polypeptides of adenovirus. I. Evidence for multiple protein components in the virion and a comparison of types 2, 7A, and 12 Virology 36 1968 115 125
32. L.J. Henry D. Xia M.E. Wilke J. Deisenhofer R.D. Gerard Characterization of the knob domain of the adenovirus type 5 fiber protein expressed in Escherichia coli J. Virol. 68 1994 5239 5246
33. Z.L. Xu H. Mizuguchi A. Ishii-Watabe E. Uchida T. Mayumi T. Hayakawa Optimization of transcriptional regulatory elements for constructing plasmid vectors Gene 272 2001 149 156
34. N. Koizumi H. Mizuguchi T. Hosono A. Ishii-Watabe E. Uchida N. Utoguchi Y. Watanabe T. Hayakawa Efficient gene transfer by fiber-mutant adenoviral vectors containing RGD peptide Biochim. Biophys. Acta 1568 2001 13 20
35. Q.L. Matthews D.A. Sibley H. Wu J. Li M.A. Stoff-Khalili R. Waehler J.M. Mathis D.T. Curiel Genetic incorporation of a herpes simplex virus type 1 thymidine kinase and firefly luciferase fusion into the adenovirus protein IX for functional display on the virion Mol. Imaging 5 2006 510 519
36. J. Li L. Le D.A. Sibley J.M. Mathis D.T. Curiel Genetic incorporation of HSV-1 thymidine kinase into the adenovirus protein IX for functional display on the virion Virology 338 2005 247 258
37. R.A. Meulenbroek K.L. Sargent J. Lunde B.J. Jasmin R.J. Parks Use of adenovirus protein IX (pIX) to display large polypeptides on the virion — generation of fluorescent virus through the incorporation of pIX-GFP Mol. Ther. 9 2004 617 624
38. L.P. Le M. Everts I.P. Dmitriev J.G. Davydova M. Yamamoto D.T. Curiel Fluorescently labeled adenovirus with pIX-EGFP for vector detection Mol. Imaging 3 2004 105 116
39. W.W. Colby T. Shenk Adenovirus type 5 virions can be assembled in vivo in the absence of detectable polypeptide IX J. Virol. 39 1981 977 980
40. G. Ghosh-Choudhury Y. Haj-Ahmad F.L. Graham Protein IX, a minor component of the human adenovirus capsid, is essential for the packaging of full length genomes EMBO J. 6 1987 1733 1739
41. P.S. Furcinitti J. van Oostrum R.M. Burnett Adenovirus polypeptide IX revealed as capsid cement by difference images from electron microscopy and crystallography EMBO J. 8 1989 3563 3570
42. M. Rosa-Calatrava L. Grave F. Puvion-Dutilleul B. Chatton C. Kedinger Functional analysis of adenovirus protein IX identifies domains involved in capsid stability, transcriptional activity, and nuclear reorganization J. Virol. 75 2001 7131 7141
43. H. Wu T. Han N. Belousova V. Krasnykh E. Kashentseva I. Dmitriev M. Kataram P.J. Mahasreshti D.T. Curiel Identification of sites in adenovirus hexon for foreign peptide incorporation J. Virol. 79 2005 3382 3390
44. J. Vellinga T.G. Uil J. de Vrij M.J. Rabelink L. Lindholm R.C. Hoeben A system for efficient generation of adenovirus protein IX-producing helper cell lines J. Gene Med. 8 2006 147 154
45. F. Gaden L. Franqueville M.K. Magnusson S.S. Hong M.D. Merten L. Lindholm P. Boulanger Gene transduction and cell entry pathway of fiber-modified adenovirus type 5 vectors carrying novel endocytic peptide ligands selected on human tracheal glandular cells J. Virol. 78 2004 7227 7247
46. C. Johansson M. Jonsson M. Marttila D. Persson X.L. Fan J. Skog L. Frangsmyr G. Wadell N. Arnberg Adenoviruses use lactoferrin as a bridge for CAR-independent binding to and infection of epithelial cells J. Virol. 81 2007 954 963
47. A.L. Parker J.H. McVey J.H. Doctor O. Lopez-Franco S.N. Waddington M.J. Havenga S.A. Nicklin A.H. Baker Influence of coagulation factor zymogens on the infectivity of adenoviruses pseudotyped with fibers from subgroup D J. Virol. 81 2007 3627 3631
48. S.N. Waddington A.L. Parker M. Havenga S.A. Nicklin S.M. Buckley J.H. McVey A.H. Baker Targeting of adenovirus serotype 5 (Ad5) and 5/47 pseudotyped vectors in vivo: fundamental involvement of coagulation factors and redundancy of CAR binding by Ad5 J. Virol. 81 2007 9568 9571